Form 4 for ZYME Zymeworks Inc.
Accepted 2026-07-06 17:29:24 ET · period of report 2026-07-06 · accession 0002104446-26-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-06 17:29 | 2026-07-06 | ZYME | Hollywood Mark | EVP, COO | A - Grant | $22.22 | +939 | 133.9K | +0.7% | +$20.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-06 | A | A | 939 | $22.22 | 133,852 | D | — | — | (F1) The shares were acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") for the ESPP purchase period of January 1, 2026 to June 30, 2026. (F2) The purchase price reflects a 15% discount to the closing price of the Issuer's Common Stock on June 30, 2026 pursuant to the provisions of the ESPP. |